(Stroke. 1996;27:1459-1466.)
© 1996 American Heart Association, Inc.
Articles |
Lifetime Cost of Stroke in the United States
the Program in Pharmaceutical Outcomes and Policy Research, College of Pharmacy (T.N.T., J.W.M.), the Department of Neurology (P.H.D.), the Department of Preventive Medicine and Environmental Health (J.C.T.), and the Department of Social Work (J.H., M.F.J.), University of Iowa (Iowa City).
Correspondence to Thomas N. Taylor, PhD, College of Pharmacy, S518 Pharmacy Bldg, University of Iowa, Iowa City, IA 52242. E-mail ttaylor@blue.weeg.uiowa.edu.
Background and Purpose Stroke imposes a substantial economic burden on individuals and society. This study estimates the lifetime direct and indirect costs associated with the three major types of stroke: subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (ISC).
Methods We developed a model of the lifetime cost of incident strokes occurring in 1990. An epidemiological model of stroke incidence, survival, and recurrence was developed based on a review of the literature. Data on direct cost of treating stroke were obtained from Medicare claims data, the 1987 National Medical Expenditure Survey (NMES), and insurance claims data representing a group of large, self-insured employers. Indirect costs (the value of foregone market and nonmarket production) associated with premature morbidity and mortality were estimated based on data from the US Bureau of Economic Analysis and the 1987 NMES.
Results The lifetime cost per person of first strokes occurring in 1990 is estimated to be $228 030 for SAH, $123 565 for ICH, $90 981 for ISC, and $103 576 averaged across all stroke subtypes. Indirect costs accounted for 58.0% of lifetime costs. Aggregate lifetime cost associated with an estimated 392 344 first strokes in 1990 was $40.6 billion: $5.6 billion for SAH, $6.0 billion for ICH, and $29.0 billion for ISC. Acute-care costs incurred in the 2 years following a first stroke accounted for 45.0%, long-term ambulatory care accounted for 35.0%, and nursing home costs accounted for 17.5% of aggregate lifetime costs of stroke.
Conclusions The lifetime cost of stroke varies considerably by type of stroke and entails considerable costs beyond the first 2 years after a stroke.
Key Words: cost and cost analysis • epidemiology • incidence
This article has been cited by other articles:
 |
|
 |
|
  G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 630S - 669S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Carmichael Themes and Strategies for Studying the Biology of Stroke Recovery in the Poststroke Epoch Stroke, April 1, 2008; 39(4): 1380 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Demaerschalk, B. J. Bobrow, and M. Paulsen Development of a Metropolitan Matrix of Primary Stroke Centers: The Phoenix Experience Stroke, April 1, 2008; 39(4): 1246 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
|
|
W. Lo, K. Zamel, K. Ponnappa, A. Allen, D. Chisolm, M. Tang, B. Kerlin, and K. O. Yeates The Cost of Pediatric Stroke Care and Rehabilitation Stroke, January 1, 2008; 39(1): 161 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Abbruzzese and R. P. Cambria Contemporary Management of Carotid Stenosis: Carotid Endarterectomy Is Here to Stay Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2007; 19(3): 248 - 256. [Abstract] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Cutler, G. Long, E. R. Berndt, J. Royer, A.-A. Fournier, A. Sasser, and P. Cremieux The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation Health Aff., January 1, 2007; 26(1): 97 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Earnshaw, A. V. Joshi, M. R. Wilson, and J. Rosand Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage Stroke, November 1, 2006; 37(11): 2751 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brown, B. Boden-Albala, K. M. Langa, L. D. Lisabeth, M. Fair, M. A. Smith, R. L. Sacco, and L. B. Morgenstern Projected costs of ischemic stroke in the United States Neurology, October 24, 2006; 67(8): 1390 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Russell, A. V. Joshi, P. J. Neumann, L. Boulanger, and J. Menzin Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage. Neurology, October 10, 2006; 67(7): 1279 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sundquist, X. Li, and K. Hemminki Familial Risk of Ischemic and Hemorrhagic Stroke: A Large-Scale Study of the Swedish Population Stroke, July 1, 2006; 37(7): 1668 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Thom, N. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z.-J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, et al. Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 14, 2006; 113(6): e85 - e151. [Full Text] [PDF]
|
|
|
|
 |
|
 Intracranial Angioplasty & Stenting for Cerebral Atherosclerosis: A Position Statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2323 - 2327. [Full Text] [PDF]
|
|
|
|
|
|
A. W. Wojner-Alexandrov, A. V. Alexandrov, D. Rodriguez, D. Persse, and J. C. Grotta Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO) Stroke, July 1, 2005; 36(7): 1512 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S.J. Miller, M. F. Drummond, L. K. Langkilde, J. J.V. McMurray, and M. Ogren Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C41 - C54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Hummel, P. Celnik, P. Giraux, A. Floel, W.-H. Wu, C. Gerloff, and L. G. Cohen Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke Brain, March 1, 2005; 128(3): 490 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S.J. Miller, F. L. Andersson, and L. Kalra Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated? Stroke, February 1, 2005; 36(2): 360 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Feng, C. L. Dumoulin, S. Dashnaw, R. D. Darrow, R. L. DeLaPaz, P. L. Bishop, and J. Pile-Spellman Feasibility of Stent Placement in Carotid Arteries with Real-time MR Imaging Guidance in Pigs Radiology, February 1, 2005; 234(2): 558 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hur, L. S Simon, and G S. Gazelle Analysis of Aspirin-Associated Risks in Healthy Individuals Ann. Pharmacother., January 1, 2005; 39(1): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Butchart and C. Gohlke-Barwolf Anticoagulation management of patients with prosthetic valves J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1143 - 1144. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cykert, N. Phifer, and C. Hansen Tamoxifen for Breast Cancer Prevention: A Framework for Clinical Decisions Obstet. Gynecol., September 1, 2004; 104(3): 433 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Woo, M. Haverbusch, P. Sekar, B. Kissela, J. Khoury, A. Schneider, D. Kleindorfer, J. Szaflarski, A. Pancioli, E. Jauch, et al. Effect of Untreated Hypertension on Hemorrhagic Stroke Stroke, July 1, 2004; 35(7): 1703 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rundek, K. Nielsen, S. Phillips, K. C. Johnston, M. Hux, D. Watson, and for the GAIN Americas Investigators Health Care Resource Use After Acute Stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas Trial Stroke, June 1, 2004; 35(6): 1368 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Hoerger, R. Harris, K. A. Hicks, K. Donahue, S. Sorensen, and M. Engelgau Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis Ann Intern Med, May 4, 2004; 140(9): 689 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M.A.A. Evers, J. N. Struijs, A. J.H.A. Ament, M. L.L. van Genugten, J. C. Jager, and G. A.M. van den Bos International Comparison of Stroke Cost Studies Stroke, May 1, 2004; 35(5): 1209 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hur, N. S. Nishioka, and G. S. Gazelle Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus J Natl Cancer Inst, February 18, 2004; 96(4): 316 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Mehta, R. C. Webb, A. Ergul, A. Tawak, and A. M. Dorrance Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R283 - R288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Middleton, D. Sharpe, J. Harris, A. Corbett, R. Lusby, and J. Ward Case Scenarios to Assess Australian General Practitioners' Understanding of Stroke Diagnosis, Management, and Prevention Stroke, November 1, 2003; 34(11): 2681 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Dewey, A. G. Thrift, C. Mihalopoulos, R. Carter, R. A.L. Macdonell, J. J. McNeil, and G. A. Donnan Lifetime Cost of Stroke Subtypes in Australia: Findings From the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, October 1, 2003; 34(10): 2502 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Higashida and A. J. Furlan Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke Stroke, August 1, 2003; 34 (8): e109 - e137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A Carroll, M. M Coen, and R. W Piepho Economic Impact of Ramipril on Hospitalization of High-Risk Cardiovascular Patients Ann. Pharmacother., March 1, 2003; 37(3): 327 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoneda, T. Uehara, H. Yamasaki, Y. Kita, M. Tabuchi, and E. Mori Hospital-Based Study of the Care and Cost of Acute Ischemic Stroke in Japan Stroke, March 1, 2003; 34(3): 718 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Bosch, J. A. Kaufman, M. T. Beinfeld, M. E. A. P. M. Adriaensen, D. C. Brewster, and G. S. Gazelle Abdominal Aortic Aneurysms: Cost-effectiveness of Elective Endovascular and Open Surgical Repair Radiology, November 1, 2002; 225(2): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Daoud, G. Mies, A. Smialowska, L. Olah, K.-A. Hossmann, and S. Stamm Ischemia Induces a Translocation of the Splicing Factor tra2-beta 1 and Changes Alternative Splicing Patterns in the Brain J. Neurosci., July 15, 2002; 22(14): 5889 - 5899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.B.W.E.M. Roos, M.G.W. Dijkgraaf, K.W. Albrecht, L.F.M. Beenen, R.J.M. Groen, R.J. de Haan, and M. Vermeulen Direct Costs of Modern Treatment of Aneurysmal Subarachnoid Hemorrhage in the First Year After Diagnosis Stroke, June 1, 2002; 33(6): 1595 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The CDC Diabetes Cost-effectiveness Group Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes JAMA, May 15, 2002; 287(19): 2542 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Stefani, P. J. Porter, K. G. terBrugge, W. Montanera, R. A. Willinsky, and M. C. Wallace Large and Deep Brain Arteriovenous Malformations Are Associated With Risk of Future Hemorrhage Stroke, May 1, 2002; 33(5): 1220 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Kissela, L. Sauerbeck, D. Woo, J. Khoury, J. Carrozzella, A. Pancioli, E. Jauch, C. J. Moomaw, R. Shukla, J. Gebel, et al. Subarachnoid Hemorrhage: A Preventable Disease With a Heritable Component Stroke, May 1, 2002; 33(5): 1321 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Micieli, A. Cavallini, and S. Quaglini Guideline Compliance Improves Stroke Outcome: A Preliminary Study in 4 Districts in the Italian Region of Lombardia Stroke, May 1, 2002; 33(5): 1341 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Djousse, R. C. Ellison, A. Beiser, A. Scaramucci, R. B. D'Agostino, and P. A. Wolf Alcohol Consumption and Risk of Ischemic Stroke: The Framingham Study Stroke, April 1, 2002; 33(4): 907 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.M. Dewey, A.G. Thrift, C. Mihalopoulos, R. Carter, R.A.L. Macdonell, J.J. McNeil, and G.A. Donnan Informal Care for Stroke Survivors: Results From the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, April 1, 2002; 33(4): 1028 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Post, J. Kievit, J. M. van Baalen, W. B. van den Hout, and J. H. van Bockel Routine Duplex Surveillance Does Not Improve the Outcome After Carotid Endarterectomy: A Decision and Cost Utility Analysis Stroke, March 1, 2002; 33(3): 749 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Dressman and J. Hunter Stroke Awareness and Knowledge Retention in Children: The Brain Child Project Stroke, February 1, 2002; 33(2): 623 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Muller, R. Bergemann, and GELIA Study Group Economic analysis of bleeding and thromboembolic sequelae after heart valve replacement (GELIA 7) Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q65 - Q69. [Abstract] [PDF]
|
|
|
|
|
|
H. M. Dewey, A. G. Thrift, C. Mihalopoulos, R. Carter, R. A.L. Macdonell, J. J. McNeil, and G. A. Donnan Cost of Stroke in Australia From a Societal Perspective: Results From the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, October 1, 2001; 32(10): 2409 - 2416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Reed, D. K. Blough, K. Meyer, and J. G. Jarvik Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals Neurology, July 24, 2001; 57(2): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Grieve, J. Hutton, A. Bhalla, D. Rastenyte, D. Ryglewicz, C. Sarti, M. Lamassa, M. Giroud, R. Dundas, and C.D.A. Wolfe A Comparison of the Costs and Survival of Hospital-Admitted Stroke Patients Across Europe Stroke, July 1, 2001; 32(7): 1684 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Quilliam, K. L. Lapane, and C. Leibson Clinical Correlates and Drug Treatment of Residents With Stroke in Long-Term Care Editorial Comment Stroke, June 1, 2001; 32(6): 1385 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. III, S. B. Fain, J. T. Wald, P. H. Luetmer, C. H. Rydberg, D. J. Covarrubias, S. J. Riederer, M. A. Bernstein, R. D. Brown, F. B. Meyer, et al. Carotid Artery: Elliptic Centric Contrast-enhanced MR Angiography Compared with Conventional Angiography Radiology, January 1, 2001; 218(1): 138 - 143. [Abstract] [Full Text]
|
|
|
|
|
|
L. Claesson, G. Gosman-Hedstrom, M. Johannesson, B. Fagerberg, and C. Blomstrand Resource Utilization and Costs of Stroke Unit Care Integrated in a Care Continuum: A 1-Year Controlled, Prospective, Randomized Study in Elderly Patients : The Goteborg 70+ Stroke Study Stroke, November 1, 2000; 31(11): 2569 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rundek, H. Mast, A. Hartmann, B. Boden-Albala, L. Lennihan, I.-F. Lin, M. C. Paik, and R. L. Sacco Predictors of resource use after acute hospitalization: The Northern Manhattan Stroke Study Neurology, October 24, 2000; 55(8): 1180 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Sarasin, J.-M. Gaspoz, and H. Bounameaux Cost-effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack Arch Intern Med, October 9, 2000; 160(18): 2773 - 2778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Liu, J. E. Manson, M. J. Stampfer, K. M. Rexrode, F. B. Hu, E. B. Rimm, and W. C. Willett Whole Grain Consumption and Risk of Ischemic Stroke in Women: A Prospective Study JAMA, September 27, 2000; 284(12): 1534 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. White, R. J. Simes, N. E. Anderson, G. J. Hankey, J. D.G. Watson, D. Hunt, D. M. Colquhoun, P. Glasziou, S. MacMahon, A. C. Kirby, et al. Pravastatin Therapy and the Risk of Stroke N. Engl. J. Med., August 3, 2000; 343(5): 317 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Alberts, G. Hademenos, R. E. Latchaw, A. Jagoda, J. R. Marler, M. R. Mayberg, R. D. Starke, H. W. Todd, K. M. Viste, M. Girgus, et al. Recommendations for the Establishment of Primary Stroke Centers JAMA, June 21, 2000; 283(23): 3102 - 3109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Elliott, D. R. Weir, and H. R. Black Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients Arch Intern Med, May 8, 2000; 160(9): 1277 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Smith and B. E. Hillner Tamoxifen Should be Cost-Effective in Reducing Breast Cancer Risk in High-Risk Women J. Clin. Oncol., January 14, 2000; 18(2): 284 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|